Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 1625 of 3499 entries
View as:

Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies

Phase: N/A Priority: Normal
NCT ID: NCT04266093 Org: User:
Start: 05/08/20 End: 10/01/50 Due: 10/01/51

Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial

Phase: N/A Priority: Normal
NCT ID: NCT03801902 Org: User:
Start: 10/28/19 End: 04/25/26 Due: 04/25/27

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04310007 Org: User:
Start: 07/13/20 End: 09/30/25 Due: 09/30/26

A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT03698019 Org: User:
Start: 02/15/19 End: 10/31/25 Due: 10/31/26

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT03984448 Org: User:
Start: 10/22/19 End: 04/01/28 Due: 04/01/29

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT06311214 Org: User:
Start: 03/18/25 End: 03/31/28 Due: 03/31/29

In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients

Phase: N/A Priority: Normal
NCT ID: NCT00001336 Org: User:
Start: 04/30/93 End: 02/28/03 Due: 02/28/04

Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00572728 Org: User:
Start: 12/31/08 End: 10/31/14 Due: 10/31/15

Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2

Phase: N/A Priority: Normal
NCT ID: NCT00003992 Org: User:
Start: 08/31/99 End: 03/31/09 Due: 03/31/10

Phase I Evaluation of Immunotoxin LMB-100 Administered by Normothermic, Intrapleural Perfusion Following Cytoreductive Surgery in Participants With Pleural Mesotheliomas, or Pleural Effusions From Cancers Expressing Mesothelin

Phase: N/A Priority: Normal
NCT ID: NCT05375825 Org: User:
Start: 01/31/24 End: 01/31/24 Due: 01/31/25

CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00112840 Org: User:
Start: 05/31/05 End: 09/10/15 Due: 09/10/16

Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00006062 Org: User:
Start: 07/31/00 End: 05/31/01 Due: 05/31/02

Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02052908 Org: User:
Start: 01/27/14 End: 01/05/21 Due: 01/05/22

Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00979862 Org: User:
Start: 03/31/10 End: 02/28/14 Due: 02/28/15

Colorectal Neoplasia Screening w Colonoscopy in Asymptomatic Women at Regional Navy/Army Medical Ctrs: The CONCeRN Trial

Phase: N/A Priority: Normal
NCT ID: NCT00339950 Org: User:
Start: 02/14/00 End: 07/16/20 Due: 07/16/21

Gemcitabine in Treating Children With Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00005577 Org: User:
Start: 08/31/96 End: - Due: -

Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00009906 Org: User:
Start: 12/31/00 End: 11/30/14 Due: 11/30/15

Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01507428 Org: User:
Start: 02/22/12 End: 08/01/21 Due: 08/01/22

S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00016094 Org: User:
Start: 04/30/01 End: 09/30/08 Due: 09/30/09

Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01383447 Org: User:
Start: 10/31/10 End: 04/30/12 Due: 04/30/13

Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00061048 Org: User:
Start: 05/31/03 End: 07/31/12 Due: 07/31/13

Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI

Phase: N/A Priority: Normal
NCT ID: NCT01312467 Org: User:
Start: 03/31/11 End: 12/31/14 Due: 12/31/15

Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01625156 Org: User:
Start: 05/31/12 End: 10/31/15 Due: 10/31/16

Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00082888 Org: User:
Start: 03/24/04 End: 07/05/17 Due: 07/05/18

Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00253630 Org: User:
Start: 09/30/05 End: 05/31/16 Due: 05/31/17